By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoString Technologies today said that it has received ISO 13485:2003 certification for its nCounter Analysis System, which includes its multiplex molecular detection instrument and reagents.

The certification, from the International Organization for Standardization, covers the design, development, production, sales, and service of the nCounter system. The certificate was awarded by G-MED North America, a subsidiary of LNE.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.